Emergent BioSolutions
A specialty pharmaceutical company which develops, manufactures and delivers a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases.
The company also develops and commercializes therapeutics and other specialty products such as vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Latest Emergent BioSolutions News & Features
12 January 2024
5 December 2023
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze